Merck Research Laboratories
3
26M
2
0.18
0.33
1
- Areas of investment
Summary
In 2004 was created Merck Research Laboratories, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Boston. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Merck Research Laboratories, startups are often financed by Polaris Partners, Flagship Pioneering, Omega Funds. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, Polaris Partners. In the next rounds fund is usually obtained by Vertex Ventures HC, Vertex Ventures, Polaris Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Imago BioSciences, Visterra. The fund has no exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics.
The high activity for fund was in 2014. Opposing the other organizations, this Merck Research Laboratories works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.18
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Clinical Trials (2)
- Health Diagnostics (2)
- Therapeutics (2)
- Medical (1) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 215M
- Group Appearance index
- 1.00
- Avg. company exit year
- 11
- Avg. multiplicator
- 3.43
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Visterra | 01 Jun 2016 | Biotechnology, Health Diagnostics, Therapeutics, Clinical Trials | Late Stage Venture | 23M | United States, Cambridge, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.